Back

Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Science: ablation Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Assistant Professor David ZIZEK

University Medical Centre Ljubljana, Ljubljana (Slovenia)

9 More presentations in this session

Presentation thumbnail
The Safety and Effectiveness of Ultra-low Temperature Cryoablation of Monomorphic VT in Patients with Ischemic and Non-Ischemic Cardiomyopathies
Doctor A. Verma (Montreal, CA)
Slides Video
Presentation thumbnail
The Safety and Effectiveness of Ultra-low Temperature Cryoablation of Monomorphic VT in Patients with Ischemic and Non-Ischemic Cardiomyopathies - discussion
Doctor U. Tedrow (Boston, US)
Slides Video
Presentation thumbnail
First-in-Human Clinical Series of a Novel Conformable "Single-Shot" Pulsed Field Ablation Catheter for Pulmonary Vein Isolation
Professor V. Reddy (New York City, US)
Slides Video
Presentation thumbnail
First-in-Human Clinical Series of a Novel Conformable "Single-Shot" Pulsed Field Ablation Catheter for Pulmonary Vein Isolation - discussion
Professor J. Kalman (Melbourne, AU)
Slides Video
Presentation thumbnail
Ablation STrategies for Repeat PrOcedures in Patients with Atrial Fibrillation Recurrences despite Durable Pulmonary Vein Isolation
Doctor B. Schmidt (Frankfurt, DE)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Science: ablation
Video

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources